Vantage logo

Your 2023 wildcard predictions revealed

Will biotech lead a bull market recovery? Will Novartis spin off its cell therapy business? Read on for some of your leftfield predictions for biopharma.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.